The Recall Desk
LowFDA (Food)·F-0926-2020·Announced 2020-05-06

Calci-Max Dietary Supplement Recalled for Zinc Content Deficiency

Alfa Vitamins Laboratories is recalling Calci-Max dietary supplements because FDA testing found the product contained 0.0% of the labeled zinc content.

What this means for you

Cosmetic or documentation issue. No expected health impact, but the manufacturer is correcting the affected products.

Our severity reasoning: The recall is classified as FDA Class III, which the rubric defines as typically resulting in a score of 1 or 2 because it is unlikely to cause adverse health consequences. The hazard is a labeling/quality discrepancy rather than a safety risk like contamination or injury.

Plain-English summary

Alfa Vitamins Laboratories, Inc. is recalling 1,877 bottles of CALCI-MAX Dietary Supplement, 60 capsules, manufactured for DOMEL. The recall is limited to Lot 31453, with a manufacture date of 06 2019 and an expiration date of 06 2022. The product was distributed domestically only.

The recall was initiated after FDA sample analysis showed that the zinc content of the affected lot was 0.0% of the label claim. This means the product does not contain the amount of zinc stated on the packaging.

Consumers who have this specific lot of Calci-Max should stop using the product and contact the recalling firm for further instructions or a refund. The recall is classified as Class III by the FDA, indicating that use of or exposure to the violative product is not likely to cause adverse health consequences.

The recalled product

Product
CALCI-MAX Dietary Supplement, 60 capsules, Manufactured for: DOMEL
Affected units
1,877

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (1)

  • LOT 31453 MFG 06 2019 EXP 06 2022

Distribution

Distribution scope not specified by the agency.